Company profile
Global Roundtable Corporation
OTC: GRCU · Healthcare · Medical - Pharmaceuticals
#848 of 1,418 Healthcare companies by revenuebottom-quartile growth
EA Score
——FH —DQ —GM —SS 49
v0.1 · 5/100 weight · pillars only
↑ 3-yr revenue growth, listing tenure · ↓ growth stability, revenue growth (YoY)
Methodology →Revenue TTM
$1.3M
Rev growth YoY (TTM)
-42.2%
Net income (FY)
-$243.2k
Employees
20
as of 2026-08-27
Market cap
$722.7k
as of 2026-08-27
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$1.3M$1.3M2024
Net income-$243.2k-$243.2k2024
Operating income-$226.3k-$226.3k2024
Total assets$2.0M$2.0M2024
Liabilities$1.4M$1.4M2024
Equity$656.1k$656.1k2024
Revenue trend
FY2017 – FY2024 · USD
FY17
FY18
FY19
FY20
FY21
FY22
FY23
FY24
Revenue by segment
No segmentation disclosed for this filer. n/a
The read
What is Global Roundtable Corporation’s revenue?
Global Roundtable Corporation booked $1.3M in FY2024 revenue, contracting 45% year over year — slower than 80% of Healthcare companies we track, at a -18.7% net margin.
Peers · Healthcare
OneMedNet Corporation26DPanbela Therapeutics, Inc.——Electromedical Technologies, Inc.——Inhibrx Biosciences Inc.28DBhang Inc.——Certive Solutions Inc.——Neighbors
Denver →Key facts
CEORich Thomas
SectorHealthcare
IndustryMedical - Pharmaceuticals
HeadquartersDenver, CO
ExchangeOTC: GRCU
Employees20
IPO date2005-02-09
Latest filings
No filings loaded — no CIK (non-SEC filer).
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.